Adalimumab/infliximabDevelopment of anti-drug antibodies: 7 case reports

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2018年 / 1701卷 / 1期
关键词：
D O I：
10.1007/s40278-018-45847-7
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：15 / 15
相关论文
共 50 条
  • [41] Adalimumab serum levels and anti-drug antibodies: associations to treatment response and drug survival in inflammatory joint diseases
    Jyssum, Ingrid
    Gehin, Johanna E.
    Sexton, Joseph
    Kristianslund, Eirik Klami
    Hu, Yi
    Warren, David John
    Kvien, Tore K.
    Haavardsholm, Espen A.
    Syversen, Silje Watterdal
    Bolstad, Nils
    Goll, Guro Lovik
    [J]. RHEUMATOLOGY, 2024, 63 (06) : 1746 - 1755
  • [42] Anti-adalimumab and anti-certolizumab antibodies titers after discontinuation of adalimumab: two case reports
    Grossi, Valentina
    Infantino, Maria
    Manfredi, Mariangela
    Basile, Umberto
    Gulli, Francesca
    Marino, Mariapaola
    Li Gobbi, Francesca
    Damiani, Arianna
    Atzeni, Fabiola
    Benucci, Maurizio
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2020, 58 (04) : E105 - E108
  • [43] Dose escalation of adalimumab as a strategy to overcome anti-drug antibodies: A case report of infantile-onset inflammatory bowel disease
    Ancona, Silvana
    Signa, Sara
    Longo, Chiara
    Cangemi, Giuliana
    Carfora, Roberta
    Drago, Enrico
    La Rosa, Alessandro
    Crocco, Marco
    Chiaro, Andrea
    Gandullia, Paolo
    Arrigo, Serena
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2023, 29 (38) : 5428 - 5434
  • [44] InfliximabDevelopment of antibodies: case report
    [J]. Reactions Weekly, 2016, 1587 (1) : 159 - 159
  • [45] Evaluating the Performance of Two Automated Anti-drug Antibodies Assays for Infliximab and Adalimumab Without Acid Dissociation
    Karsten, Carley
    Grannas, Karin
    Bergman, Oskar
    Moverare, Robert
    Roforth, Matthew
    Willrich, Maria Alice V.
    Snyder, Melissa R.
    Yang, Yifei K.
    [J]. AAPS JOURNAL, 2024, 26 (05):
  • [46] Adalimumab Serum Concentrations or Anti-Drug Antibodies Do Not Influence Fatigue in Patients with Crohn's Disease
    Karlsen, Lars Normann
    Carlsen, Arne
    Omdal, Roald
    Aabakken, Lars
    Bolstad, Nils
    Lundin, Knut
    Grimstad, Tore
    [J]. INFLAMMATORY BOWEL DISEASES, 2017, 23 : S44 - S45
  • [47] Disappearance of anti-drug antibodies to infliximab and adalimumab after addition of an immunomodulator in patients with inflammatory bowel disease
    Strik, A.
    van den Brink, G.
    Ponsioen, C.
    Mathot, R.
    Lowenberg, M.
    D'Haens, G.
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S69 - S70
  • [48] ADALIMUMAB AND ANTI-DRUG ANTIBODIES IN A COHORT OF CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS: A SINGLE-CENTER EXPERIENCE
    Tarantino, G.
    Marafon, D. Pires
    Comitini, F.
    Simeoli, R.
    Aquilani, A.
    Nicolai, R.
    Marasco, E.
    De Benedetti, F.
    Magni-Manzoni, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 680 - 680
  • [49] Anti-TNF and Anti-Drug Antibodies Levels Predict the Outcomes of Interventions After Loss of Response to Adalimumab and Infliximab
    Yanai, Henit
    Lichtenstein, Lev
    Assa, Amit
    Mazor, Yoav
    Weiss, Batia
    Levine, Arie
    Ron, Yulia
    Kopylov, Uri
    Bujanover, Yoram
    Rosenbach, Yoram
    Ungar, Bella
    Eliakim, Abraham R.
    Chowers, Yehuda
    Shamir, Raanan
    Fraser, Gerald
    Dotan, Iris
    Ben-Horin, Shomron
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S381 - S381
  • [50] Relationship Between Adalimumab Concentrations, Plasma Cytokines, Anti-drug Antibodies and Disease Activity in Rheumatoid Arthritis
    Stamp, Lisa
    Keating, Paula
    Frampton, Christopher
    Barclay, Murray
    Fanning, Niamh
    Millier, Melanie
    Hessian, Paul
    O'Donnell, John
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
12345